About
Small Molecule
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
648
By Phase
PHASE2: 3NA: 1PHASE1: 6PHASE2/PHASE3: 1
By Status
COMPLETED: 8TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05919680Lead Sponsor
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
PHASE2Recruiting
36 participants
Started: Jan 15, 2024 · Completed: Jun 30, 2025
NCT06653829Lead Sponsor
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
NACompleted
20 participants
Started: Nov 6, 2023 · Completed: Aug 31, 2024
NCT05889156Lead Sponsor
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
PHASE2Completed
50 participants
Started: Jun 30, 2023 · Completed: Apr 11, 2025
NCT05368831Lead Sponsor
Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects
PHASE1Completed
24 participants
Started: Jul 19, 2022 · Completed: Sep 7, 2022
NCT05181085Lead Sponsor
Study of NST-6179 in Healthy Subjects
PHASE1Completed
70 participants
Started: Nov 11, 2021 · Completed: May 27, 2022
Locations (1)
Headquarters
Amsterdam, Netherlands
Map
Loading map...